Its the latest flashpoint between Big Pharma and GLP-1 compounding companies.…
The termination, which means Wegovy will not longer be available on Hims & Hers, sent Hims & Hers stock down…
Novo Nordisk ends its partnership with Hims & Hers over safety concerns with Wegovy distribution, citing regulatory issues and counterfeit…
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Monday after Novo Nordisk A/S (NYSE:NVO) terminated its collaboration with…
The pharmaceutical giant accuses now former partner Hims & Hers of illegal mass production and deceptive marketing to Americans.…
Novo Nordisk is halting its collaboration with Hims & Hers Health over the sale of weight loss drugs…
Novo Nordisk terminates its partnership with Hims & Hers Health, affecting the distribution of the popular weight loss drug Wegovy.…
Hims & Hers Health Inc. (HIMS) shares dropped 25.41% to $47.90 in premarket trading after Novo Nordisk (NVO) terminated direct…
The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded semaglutide…
The partnership had been touted as a way to boost obesity-drug sales in the US…
Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in…
Novo Nordisk said on Monday it has halted its collaboration with Hims & Hers Health on the sale of…
Novo Nordisk said Hims & Hers has “failed to adhere to the law which prohibits mass sales of compounded drugs”…
Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs"…
Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs"…
Novo Nordisk (NVO) ends its brief partnership with Hims & Hers Health due to alleged illegal compounding and deceptive marketing…
Novo Nordisk ends partnership with Hims & Hers over semaglutide concerns…
Novo Nordisk ends partnership with Hims & Hers over semaglutide concerns…
Collaboration of over one month has ended based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions…
Novo Nordisk A/S is terminating a recently formed obesity-drug partnership with Hims & Hers Health Inc. that had been touted…
U.S. equities were higher at midday as concerns oil prices would spike because of the U.S. attack on Iran diminished.…
S...…
Hims & Hers stock falls after Novo Nordisk ends weight loss drug pact…
Hims & Hers stock falls after Novo Nordisk ends weight loss drug pact…
Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight…
Shares of Hims & Hers Health (NYSE:HIMS) fell around 30% on Monday after Novo Nordisk (NYSE:NVO) terminated its collaboration with…
COPENHAGEN (Reuters) -Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health…
Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight…
Novo Nordisk ends collaboration with Hims & Hers over weight loss drug sale…
Novo Nordisk OMXCOP:NOVO_B said on Monday it would halt its collaboration with Hims & Hers Health over the sale of…
Block & Leviton is investigating Hims & Hers Health, Inc. (NYSE: HIMS) for potential securities law violations. Investors should contact…
Hims & Hers stock crashes 30% on Monday after news of Novo Nordisk ending their partnership. Is HIMS now a…
Hims & Hers Health ( ($HIMS) ) has risen by 7.43%. Read on to learn why. Hims & Hers Health…
Hims & Hers Health ( ($HIMS) ) has risen by 7.43%. Read on to learn why. Hims & Hers Health…
Hims & Hers Health (NYSE:HIMS) recently announced the introduction of affordable access to Wegovy, a significant move aimed at improving…
NEW YORK – Hims & Hers Health, Inc. (NYSE: HIMS), the innovative telehealth company, has emerged as a growth juggernaut…
Paris (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse der BNP Paribas:
Der US-Telemedizin-Anbieter Hims & Hers Health Inc. (ISIN: US4330001060, WKN: A2QMYY,…
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its bumpy…
Hims & Hers (HIMS) defends recovery with personalized healthcare adoption, GLP-1 partnerships, and profit growth. Click here to read my…
San Francisco-based Hims & Hers joined the Stock Spotlight list Wednesday after it announced its buying European health site ZAVA.…
Hims & Hers (HIMS) stock is on a tear, and some analysts think Wall Street still isn’t bullish enough.…
The market is underestimating how much potential Hims & Hers has long-term.…
The market is underestimating how much potential Hims & Hers has long-term.…
The market is underestimating how much potential Hims & Hers has long-term.…
Hims & Hers Health shares rocketed higher over the last year, rewarding investors.…
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health…
Hims & Hers Health ( ($HIMS) ) just unveiled an update. On June 12, 2025, Hims & Hers Health, Inc.…
Telehealth leader Hims & Hers Health, Inc. closed the trading day on the New York Stock Exchange at 2.03 (-3.40%),…
Hims & Hers has been able to distinguish itself in a crowded field with its personalization strategy. Hims &…
What Happened?
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%)…